ETH News

02.06.2017 | News

How killer cells take out tumours

The use of immunotherapy to treat cancer is celebrating its first successes – but there are still many knowledge gaps in the underlying mechanisms of action. In a study of mice with soft tissue tumours, ETH researchers have now shown how endogenous killer cells track down the tumours with the help of dormant viruses. Read more 

29.05.2017 | News

Detailed view of a molecular toxin transporter

Transport proteins in the cells of our body protect us from particular toxins. Researchers at ETH Zurich and the University of Basel have now determined the high-resolution three-dimensional structure of a major human transport protein. In the long term, this could help to develop new medications. Read more 

24.05.2017 | News

Revealing how neurons communicate

The ETH spinoff MaxWell Biosystems AG develops microelectrode platforms for electrophysiological tests on nerve cells, opening up new possibilities for pharmaceutical research. Now, the company received CHF 130,000 in starting capital from the Venture Kick initiative Read more 

25.04.2017 | News

A novel form of iron for fortification of foods

Whey protein nanofibrils loaded with iron nanoparticles: ETH researchers are developing a new and highly effective way of fortifying iron into food and drinks. Read more 

05.04.2017 | Press release

The ETH department is well established in Basel

Ten years ago, ETH Zurich established its first and only department outside Zurich: the Department of Biosystems Science and Engineering in Basel. ETH will soon expand its outpost. The construction of a new department building on the Schällemätteli campus will bring it right next to the University of Basel. Read more 

07.03.2017 | Globe magazine | 1 Comment

An app that saves children's lives

In remote villages in Peru, pneumonia is one of the most common causes of death in children. Now researchers from ETH Zurich are in the process of developing an app to help identify the illness early on. Read more 

10.01.2017 | News

In a simple way to great complexity

ETH microbiologists have succeeded in showing that nature produces one of the most complex known bioactive natural products in a staggeringly simple way. The molecule originates from bacteria living in sea sponges. In future, it may be possible to produce the agent very easily using biotechnology, making it an interesting avenue for cancer research. Read more 

15.11.2016 | Press release | 5 Comments

High-fat diet disrupts brain maturation

The latest study by researchers from ETH Zurich and the University of Zurich suggests that excessive consumption of fatty foods could severely disrupt the development of the prefrontal cortex in the maturing brains of young people. This could potentially lead to cognitive defects in later adulthood in areas such as learning and memory, personality and impulse control. Read more 

03.11.2016 | News

Award for innovative cell culture technology

Researchers at ETH Zurich have developed a new cell culture method, which may very well enable to forgo certain tests on animals in the future. The scientists were awarded an international prize for more humane treatment of laboratory animals. Read more 

25.10.2016 | News

Iron supplements in the fight against lead

Targeted iron supplements in biscuits can achieve a striking reduction in the level of lead in children’s blood in regions with high exposure to this toxic heavy metal. This has been demonstrated for the first time by an ETH-led research group in a study of schoolchildren in Morocco. Read more 

18.10.2016 | News

Polybahn-Pitch with Volkmar Falk

Riding the Polybahn from Central up to ETH Zurich with Professor Volkmar Falk, head of the project Zurich Heart: he tells us in a new Polybahn Pitch why Zurich offers an unique opportunity to build the artificial heart of the future. Read more 

11.10.2016 | News

Treating the inflammation in lymphedema

ETH researchers have discovered that certain cells in the immune system suppress the development of lymphedema. Anti-inflammatory therapies could therefore be the key to treating this previously incurable condition. Read more 

07.10.2016 | News | 2 Comments

Zurich aims to extend high profile research on skin

A new interdisciplinary, large-scale project from the "Hochschulmedizin Zürich" network focuses on skin research in Zurich. This will help the city to become a world-leading centre of research in this field. Read more 

07.10.2016 | News | 1 Comment

All systems go for the Cybathlon

More than 70 teams from 25 countries will compete in the Cybathlon tomorrow, Saturday 8 October. The competitors are gradually arriving in Zurich, armed with high-tech gadgets and full of energy and excitement. In addition to victory at the Cybathlon, all are hoping that the assistive technology will soon be further improved. Read more 

27.09.2016 | News

Vigilin, the lock keeper

ETH researchers have discovered a molecule in liver cells that controls the release of fat into the bloodstream. This “lock keeper” is present in large quantities in overweight people and leads indirectly to vascular narrowing. Read more 

07.09.2016 | Globe magazine | 3 Comments

Studying medicine at ETH

Beginning in autumn 2017, ETH Zurich will be offering 100 places on its Bachelor’s degree course in medicine, an innovative course that combines medicine with natural sciences. Read more 

23.08.2016 | News

A patent for oxidised fat

ETH researchers have synthesised fatty acids in the laboratory that result from oxidative stress in the body. The laboratory variants turned out to be more potent anti-inflammatories than the natural ones, and have now been patented. Read more 

18.07.2016 | News

Visualising muscle disease

Researchers at ETH Zurich have developed a new marker substance for positron emission tomography (PET) that will allow them to monitor the progression of the degenerative muscle disease amyotrophic lateral sclerosis (ALS) in a patient’s brain. Read more 

01.07.2016 | Press release

Humans and robots set to take their marks

At the Cybathlon, 74 athletes from 25 countries will be showing how robotic technology helps them in their daily lives. In 100 days, the starting gun will be fired on the world’s first trial of bionic strength. The Swiss public broadcaster Schweizer Radio und Fernsehen (SRF) will incorporate the Cybathlon into a day of themed programming and broadcast the unique competition live. Read more 

30.06.2016 | News

Paving the way for the treatments of the future

Experts see great opportunities in the field of personalised medicine, but it will require the widespread exchange of patient data. This is one of the key lessons to emerge from this year’s Latsis Symposium at ETH Zurich. The researchers called on politicians to formulate data protection legislation so that it does not hinder progress in the field of personalised medicine. Read more 

10.06.2016 | News

Proteome of an entire family

Based on comprehensive protein data on mice, researchers at ETH Zurich and EPFL have gained new insights into the mechanism of metabolic disorders. A key factor in their success was the data compiled by the scientists on several different but closely related animals. Read more 

23.03.2016 | News

Promising method for breast cancer screening

A radiation-free and painless ultrasound method instead of a mammogram is how Orçun Göksel and Sergio Sanabria would like breast cancer screens to be carried out in the future. The technology developed by the two ETH researchers, which can also detect other diseases, was yesterday awarded the Spark Award 2016. Read more 

22.03.2016 | News

Support for diagnostics researcher

Proteins are important indicators in diagnosing diseases. A young ETH researcher has developed a method by which it is possible to test minute amounts of blood for different proteins in parallel. He has received an ETH Zurich Pioneer Fellowship for his work. Together with a fellow student, he wants to turn his test into a marketable product. Read more 

13.03.2016 | News

Quality control for genetic sequencing

Genetic sequencing is in widespread use today, but until now has not been accurate enough to identify an antibody immune response. Now, thanks to a new control system based on genetic barcodes, the technique is far more reliable – and ready for use in the development of vaccines and antibody drugs. Read more 

13.03.2016 | News

Polybahn Pitch featuring Robert Riener

Riding the Polybahn from Central up to the ETH Zurich main building with Robert Riener: the Professor for Sensory-Motor Systems at ETH Zurich tells us in a new Polybahn Pitch, why ETH Zurich is organising the Cybathlon, a competition for people with disabilities. Read more 

07.03.2016 | News

How bacteria nestle in

Nearly every second woman suffers from a bladder infection at some point in her life. Researchers from ETH Zurich and the University of Basel have now discovered how the intestinal bacterium E. coli attaches itself so successfully to the surface of the urinary tract. Read more 

28.02.2016 | News

Fascinating medicine at Treffpunkt Science City

The spring edition of the Treffpunkt Science City series begins next Sunday. The events revolve around the issue of health, and specifically, how the latest advances in research can improve it. Read more 

20.02.2016 | News

Protective covers for implants

ETH scientists have developed a membrane that protects medical implants from unwanted encapsulation by connective tissue. The researchers founded a spin-off company just over a year ago and have now been awarded funding by the start-up competition Venture Kick. Read more 

19.02.2016 | News

Breaking the vicious circle of heart failure

In patients with heart failure, the pumping power of the heart decreases in a fatal downward spiral. Pharmacologists at ETH Zurich and the University of Zurich have now succeeded in breaking this vicious circle in the mouse model. Their approach could one day also benefit humans. Read more 

12.02.2016 | News

Signpost for sentinel cells

Sentinel cells of the immune system can enter the finest lymphatic capillary vessels present in tissues. Researchers at ETH Zurich have now discovered the molecular signpost that guides these cells in the direction of the nearest lymph node. Read more 

30.01.2016 | News

The device with the fine nose

ETH scientists pushed the sensitivity limits of state-of-the-art trace gas analysers. The instruments are now ready for use in medicine, biological research and forensics. Read more 

16.12.2015 | Press release

Implant acts as a countermeasure

Scientists have developed a new, more complex type of genetic circuit, which has enabled them to successfully treat psoriasis, a chronic inflammatory skin condition, in the mouse model. Read more 

11.12.2015 | News | 1 Comment

Diagnostics with birefringence

ETH researchers led by Raffaele Mezzenga have developed a new diagnostic method. It is based on Birefringence, the ability of substances to change the polarisation state of light. With this method, doctors around the world can easily, rapidly and reliably detect malaria, Ebola or HIV to name only a few. Read more 

07.12.2015 | Press release | 1 Comment

Turning innovation into practical solutions more quickly

Wyss Zurich had its official opening today in the presence of Federal Councillor Johann Schneider-Ammann and Hansjörg Wyss, whose donation made the center possible. The aim of the joint development center created by ETH Zurich and the University of Zurich is to take innovative ideas from basic research and apply them in practice as quickly as possible. Read more 

06.12.2015 | Globe magazine | 1 Comment

Fat isn’t necessarily fat

ETH professor Christian Wolfrum is seeking out new substances with which to combat diabetes. One particular bile acid already looks promising – but he isn’t satisfied, so the search goes on. Read more 

05.12.2015 | Globe magazine

A rocket boost for master’s degree students

The Excellence Scholarship and Opportunity Programme offers support to the best incoming master’s degree students. Globe meets three talented individuals at various stages of their journeys and gives an insight into what the programme means for them. Read more 

01.12.2015 | News | 1 Comment

Genes for a longer, healthier life found

Out of a 'haystack' of 40,000 genes from three different organisms, scientists at ETH Zurich and a research consortium in Jena have found genes that are involved in physical ageing. If you influence only one of these genes, the healthy lifespan of laboratory animals is extended – and possibly that of humans, too. Read more 

12.11.2015 | News

Identifying the risk of premature birth

ETH biomechanic Sabrina Badir impressed the jury at the international ideas competition Falling Walls Lab. She developed a device that can determine the risk of a premature birth. Read more 

06.11.2015 | News

When less is really more

ETH researchers have found that therapeutic iron supplements may be less effective when given in brief intervals: A peptide molecule blocks iron absorption in the intestine even 24 hours after the iron administation. Read more 

02.11.2015 | News | 2 Comments

Increasing vitamin D supplementation

Elderly women should consume more vitamin D than previously recommended during the winter months. This is the finding of a new study just released by a team of researchers led by ETH Professor Michael B. Zimmermann. Read more 

15.10.2015 | News

Fighting age-related health impairments with mind and body

In promoting mental health, combined mental and physical training is more effective than physical training alone, as ETH human movement scientists have shown in a study of people over 70. Read more 

11.10.2015 | News

Polybahn Pitch featuring Nicole Wenderoth

Riding the Polybahn from Central up to ETH Zurich with Nicole Wenderoth: the Professor for Neural Control of Movement and head of ETH Zurich’s Institute of Human Movement Science and Sport tells us in a new Polybahn Pitch how she can influence someone else’s brain. Read more 

25.09.2015 | News

12 professors at ETH Zurich appointed

Upon application of the President of ETH Zurich, Professor Lino Guzzella, at its meeting of 23/24 September 2015 the ETH-Board appointed 12 individuals as professors. Read more 

05.09.2015 | News

MicroRNAs are digested, not absorbed

There has been a lot of controversy in recent years over the issue of whether exogenous microRNA molecules can be absorbed from food and even have a physiological effect. A new study by ETH professor Markus Stoffel using mouse models settles the question by demonstrating that the posited dietary uptake does not take place. This questions the potentially promising concept of creating functional foods based on microRNAs. Read more 

03.08.2015 | Press release

Cybathlon practice session a success

Zurich will host the first Cybathlon in autumn 2016, bringing together physically impaired people from all over the world to compete against each other using the latest assistive technologies. ETH Zurich welcomed 30 of the participating teams from 15 countries to complete a practice session at the Swiss Arena in Kloten. Read more 

10.07.2015 | News

6 professors at ETH Zurich appointed

At its meeting of 8/9 July 2015, the ETH Board appointed six professors at ETH Zurich in accordance with the application submitted by ETH Zurich President Lino Guzzella. Read more 

19.06.2015 | News | 1 Comment

Fructose powers a vicious circle

ETH researchers have found a hitherto unknown molecular mechanism that is driven by fructose and can lead to cardiac enlargement and heart failure. Read more 

13.06.2015 | Globe magazine

Renaissance of X-rays

ETH Professor Marco Stampanoni played a major role in advancing X-ray microscopy. Now, scientists can even shoot three-dimensional and extremely high-resolution films. Read more 

23.05.2015 | News

12 professors at ETH Zurich appointed

At its meeting of 20/21 March 2015, the ETH Board appointed 12 professors at ETH Zurich in accordance with the application submitted by ETH President Lino Guzzella.   Read more 

19.05.2015 | News | 1 Comment

The life and death of beta cells

ETH researchers studying microRNA – tiny strands of ribonucleic acid – in beta cells have found a type that plays a key role in cell death under stress. Read more 

08.04.2015 | News

Ironing out oxidative stress

Oxidative stress damages the immune system. Manfred Kopf and his team of ETH research scientists have now shown for the first time that higher doses of vitamin E can reduce the stress on immune cells. Read more 

02.04.2015 | News

Ribosome mapped at high resolution

Researchers have succeeded in achieving a high-resolution three-dimensional map of a comparatively large, complex and rare molecule: the complete ribosome (the protein-producing machinery) in the mitochondria (the intracellular powerhouse) of mammals. Read more 

01.04.2015 | News

Brilliant spark for personalised therapies

The 2015 Spark Award goes to a group of researchers led by ETH Professor Manfred Kopf, which has developed a method by which specific characteristics of immune cells can be identified. The technology could prove to be an important tool in personalised medicine. Read more 

27.03.2015 | News

ScopeM: Magnifying the minuscule

Need an optical or electron microscope for your research? Look no further than ScopeM. The Hönggerberg campus has been home to this technology platform since 2014. Read more 

20.03.2015 | Press release | 1 Comment

From blue pill to blue light

Taking men’s concerns seriously: ETH biotechnologists are developing a biotech solution for erectile dysfunction that consists of a gene construct and a blue light. Read more 

19.03.2015 | News

Spinal cord neurons that control pain and itch

The spinal cord transmits pain signals to the brain. But not all the impulses arrive at their destination: Certain neurons act as checkpoints and determine whether a pain signal is relayed or not. Researchers from ETH Zurich and the University of Zurich identified these neurons. Moreover, they developed means to specifically activate these neurons, which reduces not only pain – but astonishingly also alleviates itch. Read more 

09.03.2015 | Globe magazine | 1 Comment

Nose made by bioprinters

3D printers are opening up new opportunities in medicine too. A group of researchers in a team led by Marcy Zenobi-Wong is printing cartilage transplants using the body’s own cells. They are personalised and grow with the patient. Read more 

06.03.2015 | News

Personalising medicine with proteins

Ruedi Aebersold, Professor of Systems Biology, is one of the world’s leading researchers in proteomics. In the last few years, he has developed the proteomics method together with a team of international researchers to such an extent that doctors and clinical researchers can now use this technique as a tool. In an interview with ETH News, the professor at ETH Zurich and the University of Zurich explains how information from proteins can advance what is commonly known as personalised medicine. Read more 

18.02.2015 | News

Sunscreens may be harmful

Researchers at ETH Zurich asked consumers in German-speaking Switzerland how often they used sunscreens and other personal care products. The collected data make for interesting reading: part of the population applies sunscreen to the skin in quantities that could potentially be harmful to health. Read more 

17.02.2015 | News | 2 Comments

Voltage tester for beating cardiac cells

For the first time, scientists have succeeded in recording the current in membrane channels of contracting cardiac cells. To do this, the scientists combined an atomic force microscope with a widely used method for measuring electrical signals in cells. Read more 

04.02.2015 | News

Detox and software for power grids

The ETH-Zurich spin-offs Versantis and Adaptricity are heralding the beginning of a new era of detoxification methods and managing power systems. The two fledgling companies reached the third and final round of the competition Venture Kick. Both spin-offs received CHF 130,000 each in seed capital. Read more 

19.01.2015 | News

Cellulose with Braille for cells

Artificial implants such as pacemakers often cause complications because the body identifies them as foreign objects. Researchers at ETH Zurich have now demonstrated a simple method to fabricate cellulose-sheaths for implants, whose micro-structured surface makes them especially biocompatible. Read more 

15.01.2015 | News

Damaged DNA amplified

For the first time, researchers have succeeded in amplifying genes altered by activities such as smoking – with changes that can lead to lung cancer. As the amplified genes retain the altered information, this marks an important step towards quickly and efficiently localising this type of genetic alteration and improving our ability to analyse causes of cancer. Read more 

17.12.2014 | News

Science to aid independence in old age

ETH Zurich is taking part in EIT Health, a new major EU research programme. As part of the project, more than 140 European companies and research institutes are developing solutions for problems in the field of health and old age. Read more 

12.12.2014 | Press release

ETH and University of Zurich launch Wyss Translational Center Zurich

ETH Zurich and the University of Zurich are founding a new translational research centre at the interface of medicine, science and engineering: the Wyss Translational Center Zurich. A USD 120 million donation from Dr. h.c. mult. Hansjörg Wyss to the two Zurich universities is making this possible. Through an interdisciplinary approach, the new centre aims to accelerate the development and application of innovative medical therapies and groundbreaking robotic systems. Read more 

12.12.2014 | News

How blood vessels grow in the brain

Thomas Wälchli’s goal is to curb the growth of brain tumours. In his doctoral thesis at ETH Zurich, the physician examined how blood vessels develop in the brain, as this process also promotes tumour growth. The scientist developed a technique that allows new insights into the specific developmental stages of blood vessels in the brain. Read more 

11.12.2014 | News

Why tumours exhibit fatty degeneration

In cases of clear cell renal cell carcinoma – the most common type of renal cell carcinoma – the cancer cells become fatty. The reasons for this were long unclear, but ETH researchers have now found the cause: important cell structures in lipometabolism degrade more rapidly. Read more 

10.12.2014 | News

Elegant solution for the knee

A torn anterior cruciate ligament is the most common clinically relevant knee injury. Every year, more than 6,000 people are affected in Switzerland alone. Current treatment methods, although numerous, often produce inadequate results. A new implant could provide the answer. Read more 

08.12.2014 | News

Globe: Hot spot in the field of medicine

For the last two years, ETH Zurich has been working closely with the University and the University Hospital in the field of medicine under the umbrella of Hochschulmedizin Zürich. The idea: to exploit the enormous potential that the three institutions have at their fingertips and catapult Zurich onto the world stage as a hotbed of medicine. The latest issue of Globe, the magazine of ETH Zurich and ETH Alumni, reveals exactly what this means. Read more 

05.12.2014 | Globe magazine

A heart made in Zurich

A heart transplant is the only treatment for end-stage heart failure, but donor hearts are in short supply. Artificial hearts suitable for long-term use could present an alternative – and this is precisely what heart specialist Volkmar Falk is working on in the Zurich Heart project, together with Edoardo Mazza and Dimos Poulikakos from ETH Zurich. Read more 

01.12.2014 | News

How early trauma influences behaviour

Traumatic and stressful events during childhood increase the risk to develop psychiatric disorders, but to a certain extent, they can also help better deal with difficult situations later in life. Researchers have studied this phenomenon in mice to learn how these effects could be transmitted to the next generation. Read more 

18.11.2014 | News

Better micro-actuators to transport materials in liquids

Researchers have developed improved forms of tiny magnetic actuators thanks to new materials and a microscopic 3D printing technology. Read more 

18.11.2014 | News

“We still have much to achieve”

“Hochschulmedizin Zürich”, a partner association of ETH Zurich, the University of Zurich and the university hospitals, was founded three years ago. At its annual conference, the partners presented the achievements of their strengthened collaboration, along with some promising new projects for the future. Read more 

23.10.2014 | News

Flu viruses disguised as waste

Viruses cannot multiply without cellular machinery. Although extensive research into how pathogens invade cells has been conducted for a number of viruses, we do not fully understand how the shell of a virus is cracked open during the onset of infection thus releasing the viral genome. An ETH Zurich led research team discovered how this mechanism works for the influenza virus – with surprising results. Read more 

22.10.2014 | News

Precise and programmable biological circuits

A team led by ETH Professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers. Read more 

15.10.2014 | News

Emergency aid for overdoses

Every minute counts in the event of an overdose. ETH professor Jean-Christophe Leroux and his team have developed an agent to filter out toxins from the body more quickly and efficiently. It can also be used for dialysis in patients suffering from hepatic failure. Read more 

08.10.2014 | News | 1 Comment

The mathematics behind the Ebola epidemic

Researchers in the Department of Biosystems Science and Engineering at ETH Zurich have calculated new benchmark figures to precisely describe the Ebola epidemic in West Africa from a mathematical perspective. Their results may help health authorities to contain the epidemic. Read more 

07.10.2014 | News

An innovative way to combat exploding healthcare costs

At the ETH Health Talk, researchers met with representatives from business, administration and various associations to discuss the Herculean task of making the Swiss healthcare system ready for the future. Participants called for more transparency, more interdisciplinary research and better underlying data. Read more 

01.10.2014 | News

How the lungs fight the flu virus

A special type of phagocyte cells in the lungs plays an important role during infection with flu viruses by preserving the exchange of oxygen and carbon dioxide despite massive virus-induced lung tissue damage, as researchers from ETH have demonstrated. Read more 

16.09.2014 | News

Measuring modified protein structures

ETH-Zurich researchers have developed a new approach to measure proteins with structures that change. This could enable new diagnostic tools for the early recognition of neurodegenerative diseases to be developed. Read more 

15.09.2014 | News

The future of the university district: research and neighbourhood

The university district in Zurich’s city centre is to be developed further as a location for medical education, research and healthcare. At the beginning of September, the canton, the city and the universities presented the plan to local residents. Read more 

11.09.2014 | Press release

New defence mechanism against viruses discovered

Researchers have discovered that a known quality control mechanism in human, animal and plant cells is active against viruses. They think it might represent one of the oldest defence mechanisms against viruses in evolutionary history. Read more 

08.09.2014 | News | 1 Comment

Berthold sets the course for the medicine of tomorrow

The intergenerational Berthold project aims to strengthen university medicine at the Zurich centre: new buildings, parks and a campus boulevard are to be built across the premises of the university, university hospital and ETH Zurich. ETH will be given more space. Read more 

05.09.2014 | Press release

New centre for biomedical imaging

ETH Zurich and the University of Zurich are pooling their expertise in biomedical imaging technologies. Their new competence centre EXCITE Zurich aims to efficiently translate new ideas from basic research into clinical practice. The centre will be inaugurated on Saturday. Read more 

11.08.2014 | Press release | 2 Comments

Sensitive acid sensor controls insulin production

ETH Zurich researchers from the Department of Biosystems Science and Engineering (D-BSSE) in Basel have developed an implantable device that precisely monitors acid build-up in the body for people with diabetes and produces insulin if acidosis becomes a risk. Read more 

06.08.2014 | News | 36 Comments

Curing arthritis in mice

With a new therapeutic product, researchers have managed to cure arthritis in mice for the first time. The scientists are now planning to test the efficacy of the drug in humans. Read more 

03.07.2014 | News | 1 Comment

New competence centre for personalised medicine in Zurich

DNA sequencing has revolutionised life sciences. Now it’s medicine’s turn: thanks to genetic analysis, treatment tailored to individual patients will be a standard feature in the future. With a new competence centre, ETH Zurich and the University of Zurich are aiming to lead the way in personalised medicine. Read more 

02.07.2014 | News

New approach for tuberculosis drugs

In the past 50 years, only one new tuberculosis drug has come on to the market, yet many more active substances are urgently needed. Current treatments increasingly fail due to multidrug-resistant pathogens. ETH researchers have now applied to patent a novel approach for developing new tuberculosis drugs. Read more 

30.06.2014 | Press release | 2 Comments

Body odour reveals malarial infection

An infection with malaria pathogens changes the scent of infected mice, making those infected more attractive to mosquitos. These are the findings of a team of researchers from ETH Zurich and Pennsylvania State University in a new study. Read more 

13.06.2014 | News | 1 Comment

With the right rehabilitation, paralyzed rats learn to grip again

After a large stroke, motor skills barely improve, even with rehabilitation. An experiment conducted on rats demonstrates that a course of therapy combining the stimulation of nerve fiber growth with drugs and motor training can be successful. The key, however, is the correct sequence: Paralyzed animals only make an almost complete recovery if the training is delayed until after the growth promoting drugs have been administered. Read more 

12.06.2014 | News

Obesity researcher recognised

This year’s Max Rössler Prize has gone to the nutritional biologist Christian Wolfrum in the Department of Health Sciences and Technology at ETH Zurich. He received the award and its CHF 200,000 prize money for his outstanding research in the field of adipocyte biology and lipid metabolism. Read more 

05.06.2014 | News

Prize-winning UV protection and chairless chairs

Not one… but two ETH-Zurich spin-offs managed to convince the judging panel from the venture kick initiative and win an advancement award of CHF 130,000. The best start-up projects of the year’s first quarter were a sun-protection app and a chair that can walk. Read more 

27.05.2014 | News | 1 Comment

Mycotoxin protects against nematodes

Researchers at ETH Zurich have isolated a protein from a fungus of the spruce which combats nematodes. The scientists hope that toxins of this kind will become the basis for the vaccination of livestock or domestic animals against zooparasitic nematodes. Read more 

22.05.2014 | News | 1 Comment

How the gut feeling shapes fear

We are all familiar with that uncomfortable feeling in our stomach when faced with a threatening situation. By studying rats, researchers at ETH Zurich have been able to prove for the first time that our ‘gut instinct’ has a significant impact on how we react to fear. Read more 

02.05.2014 | News

Catalyst for adult-onset diabetes decoded

Researchers have discovered a key molecule that affects the onset of diabetes. This might help in the earlier detection of the disease and the development of new drugs. Read more 

08.04.2014 | Press release

Glucosamine promotes longevity by mimicking a low-carb diet

The widely used food supplement glucosamine promotes longevity in ageing mice by approximately 10% due to improved glucose metabolism. Michael Ristow, a professor at ETH Zurich, and his team find that the compound does so “by mimicking a low-carb diet in elderly mice reflecting human retirees”. Read more 

04.04.2014 | News

Virus controls progression of HIV infection

A research team has discovered that the HI virus itself determines the host viral load to a surprisingly high degree. This has a major impact on the development of HIV infections into AIDS. In an interview with ETH News the infection researchers Sebastian Bonhoeffer and Gabriel Levanthal describe how they came to this realisation and what conclusions they draw from it. Read more 

24.03.2014 | News

Hot nanoparticles for cancer treatments

Nanoparticles have a great deal of potential in medicine: for diagnostics, as a vehicle for active substances or a tool to kill off tumours using heat. ETH Zurich researchers have now developed particles that are relatively easy to produce and have a wide range of applications. Read more 

17.03.2014 | News

Follow the ant trail for drug design

New drugs often fail because they cause undesirable side-effects. ETH researchers have developed simulation software that predicts the properties of active agents and virtually builds new ones. The software’s search process is modelled after the behaviour of ants. Read more 

02.03.2014 | News

Homing in on cancer

Whether a tumour develops from individual cancer cells and whether metastases are formed depends on many factors in the affected tissue. Researchers at the University of Zurich and at ETH Zurich have come up with an imaging method that is able to simultaneously visualize a previously unachieved number of factors involved in cancer. Read more 

Page URL:
© 2017 Eidgenössische Technische Hochschule Zürich